Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss of $0.78/sh

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q4 EPS of ($0.78), versus ($0.17) reported last year.

For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says